Journal of Cancer Therapy
Vol.7 No.3(2016), Paper ID 64705, 6
pages
DOI:10.4236/jct.2016.73020
ADE as Induction Therapy Results in Treatment of Children with Non-M3 High-Risk Acute Myeloid Leukemia, an Extrapolable Achievement in Developing Countries
Marta Zapata-Tarrés, Rocío Cárdenas-Cardós, Liliana Velasco-Hidalgo, Martín Pérez-García, Alberto Olaya-Vargas, Daniela Cárdenas-Pedraza, Roberto Rivera-Luna
Oncology Department, Instituto Nacional de Pediatría, México City, México
Oncology Department, Instituto Nacional de Pediatría, México City, México
Oncology Department, Instituto Nacional de Pediatría, México City, México
Hematopoietic Stem Cell Transplantation, Instituto Nacional de Pediatría, México City, México
Hematopoietic Stem Cell Transplantation, Instituto Nacional de Pediatría, México City, México
Oncology Department, Instituto Nacional de Pediatría, México City, México
Division of Hem-Oncology, Instituto Nacional de Pediatría, México City, México
Copyright © 2016 Marta Zapata-Tarrés, Rocío Cárdenas-Cardós, Liliana Velasco-Hidalgo, Martín Pérez-García, Alberto Olaya-Vargas, Daniela Cárdenas-Pedraza, Roberto Rivera-Luna et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Zapata-Tarrés, M. , Cárdenas-Cardós, R. , Velasco-Hidalgo, L. , Pérez-García, M. , Olaya-Vargas, A. , Cárdenas-Pedraza, D. and Rivera-Luna, R. (2016) ADE as Induction Therapy Results in Treatment of Children with Non-M3 High-Risk Acute Myeloid Leukemia, an Extrapolable Achievement in Developing Countries.
Journal of Cancer Therapy,
7, 197-202. doi:
10.4236/jct.2016.73020.